53 related articles for article (PubMed ID: 19215721)
1. Human Papillomavirus Vaccination Among Young Adults Before and During the COVID-19 Pandemic.
Sonawane K; Garg A; Meissner EG; Damgacioglu H; Hill E; Nyitray AG; Deshmukh AA
JAMA Netw Open; 2024 Feb; 7(2):e2356875. PubMed ID: 38376844
[TBL] [Abstract][Full Text] [Related]
2. High coverage and adherence to dose intervals of the national school-based HPV vaccination program in Sweden during 2012-2019.
Wang J; Herweijer E; Nordqvist Kleppe S; Hartwig S; Velicer C; Koro C; Sundström K
Prev Med Rep; 2023 Oct; 35():102342. PubMed ID: 37584061
[TBL] [Abstract][Full Text] [Related]
3. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
Leval A; Herweijer E; Ploner A; Eloranta S; Fridman Simard J; Dillner J; Young C; Netterlid E; Sparén P; Arnheim-Dahlström L
J Natl Cancer Inst; 2013 Apr; 105(7):469-74. PubMed ID: 23486550
[TBL] [Abstract][Full Text] [Related]
4. Mothers' support for voluntary provision of HPV vaccine in schools.
Kadis JA; McRee AL; Gottlieb SL; Lee MR; Reiter PL; Dittus PJ; Brewer NT
Vaccine; 2011 Mar; 29(14):2542-7. PubMed ID: 21300097
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of human papillomavirus vaccination.
Dillner J; Arbyn M; Unger E; Dillner L
Clin Exp Immunol; 2011 Jan; 163(1):17-25. PubMed ID: 21062269
[TBL] [Abstract][Full Text] [Related]
6. Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review.
Chaudhary AK; Singh M; Sundaram S; Mehrotra R
Head Neck Oncol; 2009 Jun; 1():22. PubMed ID: 19555477
[TBL] [Abstract][Full Text] [Related]
7. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain.
Limia A; Pachón I
Euro Surveill; 2011 May; 16(21):. PubMed ID: 21632017
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus vaccine: a paradigm shift for pediatricians.
Jenson HB
Curr Opin Pediatr; 2009 Feb; 21(1):112-21. PubMed ID: 19242247
[TBL] [Abstract][Full Text] [Related]
10. [Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].
Westra TA; Daemen T; Postma MJ; Wilschut JC
Ned Tijdschr Geneeskd; 2009; 153():A356. PubMed ID: 19930733
[TBL] [Abstract][Full Text] [Related]
11. Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
Simoens C; Sabbe M; Van Damme P; Beutels P; Arbyn M
Euro Surveill; 2009 Nov; 14(46):. PubMed ID: 19941796
[TBL] [Abstract][Full Text] [Related]
12. Introduction of human papillomavirus (HPV) vaccination in Sweden.
Tegnell A; Dillner J; Andrae B
Euro Surveill; 2009 Feb; 14(6):. PubMed ID: 19215721
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
